It figures that PETM would pop (up 10% yesterday) the day after I take it off of my list of long candidates because I was bored with it. I guess that’s what I get for having a short attention span. 
There are a good number of lings on the list today but I probably won’t touch any of them because of expiration and the fact that i don’t want any more exposure over the weekend.
Currently holding:
Long – MACR, PLMO, SWFT, WBSN
Short – none
Looking for swing trade entries in:
Longs – AMLN, BMET, CCMP, ESRX, EWBC, LOW, MBT, SEAC, USG
Shorts – AVY, FBR
Potential day trades:
(From Briefing.com)
Gapping Down
OSIP -12% (sell-the-news reaction to sooner than expected approval of Tarceva; possible label issues), DNA -4% (partner with OSIP), RSTO -14% (misses by $0.04, guides below consensus for Q4), CRDM -27% (profit taking from 36% move yesterday), BCSI -8% (reports OctQ), LONG -7% (reports Q3), EMRG -5.4% (profit taking from 39% move yesterday), DNDN -5.3% (cut to Sell from Buy at Brean Murray), SAFM -4.7% (guides lower), MCDTA -4.3% (reports Q3), NOVL -3.7% (Pru downgrade after OctQ report), BIIB -3.3% (may take hits after Antegren data – WSJ), URBN -2.9% (Smith Barney downgrade), AMZN -2.2% (started with a Sell at BofA; tgt $26), AMD -2.1% (Goldman downgrade), AMAT -1.5% (Goldman downgrade).
Gapping Up
ADSK +8.4% (reports OctQ; 2-for-1 split), INCX +23% (recent ipo reports Q3 results), SIRI +16% (names Mel Karmazin as CEO; Wachovia upgrade), SRNA +11% (reports OctQ), MRVL +5.4% (reports OctQ), TSCM +10% (highlighted in BusinessWeek as takeover play; note Briefing.com highlighted the stock on Nov 15 for same reason), PACT +6.5% (continues recent volatility), IVIL +5.6% (Jefferies upgrade), TMWD +4.3% (Kaufman inits with $6.75 tgt), STSI +3.6%, NVDA +3.4%, DIS +2.2% (reports SepQ)…. Under $3: MRSA +24%, RNDC +20% (CIBC upgrade).
